+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Alzheimer's Disease Treatment Market Report 2026 - Product Thumbnail Image

Alzheimer's Disease Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Regenerative Medicine Market Report 2023-2033 - Product Thumbnail Image

Regenerative Medicine Market Report 2023-2033

  • Report
  • March 2023
  • 232 Pages
  • Global
From
Preeclampsia Drugs Market Report 2026 - Product Thumbnail Image

Preeclampsia Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cyclic Heavy Menstrual Bleeding Market Report 2026 - Product Thumbnail Image

Cyclic Heavy Menstrual Bleeding Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Non-cancerous Skin Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Non-cancerous Skin Diseases Therapeutics Market 2025-2029

  • Report
  • February 2025
  • 222 Pages
  • Global
From
Fibrotic Diseases Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Fibrotic Diseases Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 189 Pages
  • Global
From
From
Genomic Collaboration and Licensing Deals 2018-2025 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2025

  • Report
  • November 2025
  • 550 Pages
  • Global
From
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • April 2026
  • 158 Pages
  • Global
From
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 196 Pages
  • Global
From
Angina Pectoris Drugs - Global Strategic Business Report - Product Thumbnail Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 196 Pages
  • Global
From
Dyslipidemia Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs Market - Global Strategic Business Report

  • Report
  • April 2026
  • 268 Pages
  • Global
From
From
From
From
Loading Indicator